We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2006 by Austin Health.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00385073
First Posted: October 6, 2006
Last Update Posted: October 6, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Austin Health
October 5, 2006
October 6, 2006
October 6, 2006
April 2005
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease
Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease
Participants will complete a self-selected intensity of exercising over a 6 month period, with detailed clinical assessments at commencement and completion to determine the rate of progression of parkinsonism and gait abnormalities
Participants will complete a self-selected intensity of exercising over a 6 month period - including jogging, swimming and circuit training, with detailed clinical assessments at commencement and completion (including UPDRS, gaitrite lab study) to determine the rate of progression of parkinsonism and gait abnormalities
Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Parkinson's Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
30
December 2007
Not Provided

Inclusion Criteria:

  • Early Parkinson's Disease,
  • Able to provide informed consent,
  • able to complete exercise diaries for 6 months,
  • no medications or on levo-dopa

Exclusion Criteria:

  • Not on dopamine agonists,
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Australia
 
 
NCT00385073
126/05
Not Provided
Not Provided
Not Provided
Not Provided
Austin Health
Not Provided
Principal Investigator: mary m galea, PgD Austin Health
Austin Health
October 2006